SLGL supply chain intelligence for Sol-Gel Technologies Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 72% | Reciprocal relationship from ACRS graph: Reciprocal relationship from SLGL graph: se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Me… |
| ACRS | Aclaris Therapeutics, Inc. | 72% | se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mexico and Israel. These registrations cover potential brand names for our Epsolay i… |
| BHC | Bausch Health Companies Inc. | 72% | Reciprocal relationship from BHC graph: Reciprocal relationship from SLGL graph: Reciprocal relationship from BHC graph: Reciprocal relationship from SLGL graph: se. We have four registered trademark… |
| BHC | Bausch Health Companies Inc. | 72% | se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mexico and Israel. These registrations cover potential brand names for our Epsolay i… |
| NVSEF | Novartis AG | 72% | se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mexico and Israel. These registrations cover potential brand names for our Epsolay i… |
| NVSEF | Novartis AG | 72% | Reciprocal relationship from NVSEF graph: Reciprocal relationship from SLGL graph: Reciprocal relationship from NVSEF graph: Reciprocal relationship from SLGL graph: se. We have four registered trade… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from SLGL graph: se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, M… |
| ORANY | ORANY | 72% | se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mexico and Israel. These registrations cover potential brand names for our Epsolay i… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| PADAGIS-ISRAEL-PHARMACEUTICALS-LTD | PADAGIS-ISRAEL-PHARMACEUTICALS-LTD | 85% | NOTE 8 — COLLABORATION AGREEMENTS: a. In 2007, the Company sublicensed rights to a third party for use and commercialization of a product for skin protection. Under this agreement, the Company is ent… |
| ACRS | Aclaris Therapeutics, Inc. | 72% | se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mexico and Israel. These registrations cover potential brand names for our Epsolay i… |
| ACRS | Aclaris Therapeutics, Inc. | 72% | Reciprocal relationship from ACRS graph: Reciprocal relationship from SLGL graph: se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Me… |
| BHC | Bausch Health Companies Inc. | 72% | Reciprocal relationship from BHC graph: Reciprocal relationship from SLGL graph: se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mex… |
| BHC | Bausch Health Companies Inc. | 72% | se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mexico and Israel. These registrations cover potential brand names for our Epsolay i… |
| NVSEF | Novartis AG | 72% | se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mexico and Israel. These registrations cover potential brand names for our Epsolay i… |
| NVSEF | Novartis AG | 72% | Reciprocal relationship from NVSEF graph: Reciprocal relationship from SLGL graph: se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, M… |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from SLGL graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from SLGL graph: Reciprocal relationship from ORAN… |
| ORANY | ORANY | 72% | se. We have four registered trademarks in Europe (including United Kingdom), Canada, the United States, Australia, Mexico and Israel. These registrations cover potential brand names for our Epsolay i… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| SLGL-DEBT-12583 | Warrants outstanding: 54144 | 90% | xbrl warrant detail from xbrl 2017-07-31. |
| SLGL-DEBT | Debt stack $991,000 | 90% | Market cache reports total debt of $991,000. |
| SLGL-DEBT-12584 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2018-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| SLGL-OWNER-OPALEYE-MANAGEMENT-INC | Opaleye Management Inc. | 90% | 13F overlay lists Opaleye Management Inc. as top holder; 20 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | 100.00 | 2 | |
| OLMA | Olema Pharmaceuticals, Inc. | 100.00 | 2 | |
| HLNCF | Haleon plc | 100.00 | 2 | |
| HLN | Haleon plc | 100.00 | 2 | |
| KLRS | Kalaris Therapeutics, Inc. | 100.00 | 2 | |
| LQDA | Liquidia Corporation | 100.00 | 2 | |
| COLL | Collegium Pharmaceutical, Inc. | 100.00 | 2 | |
| ALC | Alcon Inc. | 100.00 | 2 | |
| ABT | Abbott Laboratories | 100.00 | 2 | |
| CTMX | CytomX Therapeutics, Inc. | 100.00 | 2 | |
| BIOA | BioAge Labs, Inc. | 100.00 | 2 | |
| SDGR | Schrödinger, Inc. | 100.00 | 2 | |
| ANL | Adlai Nortye Ltd. | 100.00 | 2 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 100.00 | 2 | |
| EDSA | Edesa Biotech, Inc. | 100.00 | 2 | |
| CTNM | Contineum Therapeutics, Inc. | 100.00 | 2 | |
| CPMV | Mosaic ImmunoEngineering, Inc. | 100.00 | 2 | |
| ELVN | Enliven Therapeutics, Inc. | 100.00 | 2 | |
| BNBX | BNB Plus Corp. | 100.00 | 2 | |
| NVS | Novartis AG | 100.00 | 2 |